{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T12:24:49Z","timestamp":1774009489064,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ejpn-journal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ejpn.2021.02.009","type":"journal-article","created":{"date-parts":[[2021,3,6]],"date-time":"2021-03-06T04:54:24Z","timestamp":1615006464000},"page":"92-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Pediatric SMA patients with complex spinal anatomy: Implementation and evaluation of a decision-tree algorithm for administration of nusinersen"],"prefix":"10.1016","volume":"31","author":[{"given":"Laura","family":"Carrera-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4702-5072","authenticated-orcid":false,"given":"Jordi","family":"Muchart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Jos\u00e9","family":"Lazaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Exp\u00f3sito-Escudero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8780-1764","authenticated-orcid":false,"given":"Daniel","family":"Cuadras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julita","family":"Medina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3105-0882","authenticated-orcid":false,"given":"Magda","family":"Bosch de Basea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8526-1354","authenticated-orcid":false,"given":"Jaume","family":"Colomer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Jimenez-Mallebrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Ortez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Natera-de Benito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejpn.2021.02.009_bib1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/nbdi.1996.0010","article-title":"The neurobiology of childhood spinal muscular atrophy","volume":"3","author":"Crawford","year":"1996","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.ejpn.2021.02.009_bib2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.ejpn.2021.02.009_bib3","series-title":"Spinal Muscular Atrophies. Neuromuscular Disorders Of Infancy, Childhood, and Adolescence: A Clinician's Approach","first-page":"117","author":"Darras","year":"2015"},{"issue":"2","key":"10.1016\/j.ejpn.2021.02.009_bib4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/mus.24497","article-title":"Spinal muscular atrophy: diagnosis and management in a new therapeutic era","volume":"51","author":"Arnold","year":"2015","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.ejpn.2021.02.009_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ejhg.2011.134","article-title":"Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72 400 specimens","volume":"20","author":"Sugarman","year":"2012","journal-title":"Eur. J. Hum. Genet."},{"issue":"9630","key":"10.1016\/j.ejpn.2021.02.009_bib6","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/S0140-6736(08)60921-6","article-title":"Spinal muscular atrophy","volume":"371","author":"Lunn","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ejpn.2021.02.009_bib7","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1177\/0883073807305673","article-title":"Spinal muscular atrophy: clinical classification and disease heterogeneity","volume":"22","author":"Russman","year":"2007","journal-title":"J.\u00a0Child Neurol."},{"key":"10.1016\/j.ejpn.2021.02.009_bib8","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0960-8966(06)80015-5","article-title":"International SMA consortium meeting (26-28 june 1992, bonn, Germany)","volume":"2","author":"Munsat","year":"1992","journal-title":"Neuromuscul. Disord."},{"issue":"9","key":"10.1016\/j.ejpn.2021.02.009_bib9","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/gt.2017.52","article-title":"The clinical landscape for SMA in a new therapeutic era","volume":"24","author":"Talbot","year":"2017","journal-title":"Gene Ther."},{"issue":"9","key":"10.1016\/j.ejpn.2021.02.009_bib10","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1212\/WNL.0000000000000741","article-title":"Observational study of spinal muscular atrophy type I and implications for clinical trials","volume":"83","author":"Finkel","year":"2014","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.ejpn.2021.02.009_bib11","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1710504","article-title":"Nusinersen versus sham control in later-onset spinal muscular atrophy","volume":"378","author":"Mercuri","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"7","key":"10.1016\/j.ejpn.2021.02.009_bib12","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S1474-4422(17)30085-6","article-title":"Safety and efficacy of olesoxime in patients with type 2 or non-ambulatory type 3 spinal muscular atrophy: a randomised, double-blind, placebo-controlled phase 2 trial","volume":"16","author":"Bertini","year":"2017","journal-title":"Lancet Neurol."},{"issue":"15","key":"10.1016\/j.ejpn.2021.02.009_bib13","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1101\/gad.1941310","article-title":"Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model","volume":"24","author":"Hua","year":"2010","journal-title":"Genes Dev."},{"issue":"4","key":"10.1016\/j.ejpn.2021.02.009_bib14","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ajhg.2008.01.014","article-title":"Antisense masking of an hnRNP A1\/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice","volume":"82","author":"Hua","year":"2008","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.ejpn.2021.02.009_bib15","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1212\/WNL.0000000000007742","article-title":"Natural course of scoliosis and lifetime risk of scoliosis surgery in spinal muscular atrophy","volume":"93","author":"Wijngaarde","year":"2019","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ejpn.2021.02.009_bib16","first-page":"183","article-title":"Intrathecal administration of nusinersen in adolescent and adult SMA type 2 and 3 patients","volume":"266","author":"Wurster","year":"2019","journal-title":"J.\u00a0Neurol."},{"issue":"9840","key":"10.1016\/j.ejpn.2021.02.009_bib17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0140-6736(12)60815-0","article-title":"Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study","volume":"380","author":"Pearce","year":"2012","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ejpn.2021.02.009_bib18","first-page":"1","article-title":"Recommendations of the ICRP. ICRP publication 26","volume":"1","year":"1977","journal-title":"Ann. ICRP"},{"key":"10.1016\/j.ejpn.2021.02.009_bib19","doi-asserted-by":"crossref","DOI":"10.1177\/1756286418803246","article-title":"Feasibility and safety of intrathecal treatment with nusinersen in adult patients with spinal muscular atrophy","volume":"11","author":"Stolte","year":"2018","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.ejpn.2021.02.009_bib20","doi-asserted-by":"crossref","DOI":"10.5152\/dir.2020.19607","article-title":"Nusinersen injections in adults and children with spinal muscular atrophy: a single-center experience","author":"Ozutemiz","year":"2020","journal-title":"Diagnostic Interv Radiol"},{"key":"10.1016\/j.ejpn.2021.02.009_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/mus.26899","article-title":"Intrathecal delivery of nusinersen in individuals with complicated spines","author":"Cartwright","year":"2020","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ejpn.2021.02.009_bib22","series-title":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios","year":"2018"},{"issue":"2","key":"10.1016\/j.ejpn.2021.02.009_bib23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","article-title":"Diagnosis and management of spinal muscular atrophy: Part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care","volume":"28","author":"Mercuri","year":"2018","journal-title":"Neuromuscul. Disord."},{"issue":"1","key":"10.1016\/j.ejpn.2021.02.009_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-2982.2008.01709.x","article-title":"The international classification of headache disorders, third ed.","volume":"38","author":"Olesen","year":"2018","journal-title":"Cephalalgia"},{"key":"10.1016\/j.ejpn.2021.02.009_bib25","unstructured":"Size-Specific Dose Estimates (SSDE) in Pediatric and Adult Body CT Examinations. reportReport of AAPM Task Group 204, Developed in Collaboration with the International Commession on Radiation Units and Measurements (ICRU) and the Image Gently Campaign of the Al n.D."},{"issue":"1","key":"10.1016\/j.ejpn.2021.02.009_bib26","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejpn.2017.11.001","article-title":"Single-center experience with intrathecal administration of Nusinersen in children with spinal muscular atrophy type 1","volume":"22","author":"Pechmann","year":"2018","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"7","key":"10.1016\/j.ejpn.2021.02.009_bib27","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1177\/0883073815627882","article-title":"Intrathecal injections in children with spinal muscular atrophy: nusinersen clinical trial experience","volume":"31","author":"Hach\u00e9","year":"2016","journal-title":"J.\u00a0Child Neurol."},{"issue":"7","key":"10.1016\/j.ejpn.2021.02.009_bib28","doi-asserted-by":"crossref","first-page":"e620","DOI":"10.1212\/WNL.0000000000006006","article-title":"Cervical puncture to deliver nusinersen in patients with spinal muscular atrophy","volume":"91","author":"Veerapandiyan","year":"2018","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.ejpn.2021.02.009_bib29","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.nmd.2019.08.007","article-title":"Intrathecal administration of nusinersen in adult and adolescent patients with spinal muscular atrophy and scoliosis: transforaminal versus conventional approach","volume":"29","author":"Bortolani","year":"2019","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ejpn.2021.02.009_bib30","first-page":"1","article-title":"Lumbar laminotomy for the intrathecal administration of nusinersen for spinal muscular atrophy: technical note and outcomes","author":"Ko","year":"2019","journal-title":"J.\u00a0Neurosurg. Spine"},{"issue":"1","key":"10.1016\/j.ejpn.2021.02.009_bib31","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s00247-018-4240-7","article-title":"Ultrasound-guided cervical puncture for nusinersen administration in adolescents","volume":"49","author":"Ortiz","year":"2019","journal-title":"Pediatr. Radiol."},{"issue":"10","key":"10.1016\/j.ejpn.2021.02.009_bib32","doi-asserted-by":"crossref","first-page":"e610","DOI":"10.1097\/BPO.0000000000001247","article-title":"Preliminary safety and tolerability of a novel subcutaneous intrathecal catheter system for repeated outpatient dosing of nusinersen to children and adults with spinal muscular atrophy","volume":"38","author":"Strauss","year":"2018","journal-title":"J.\u00a0Pediatr. Orthop."},{"issue":"5","key":"10.1016\/j.ejpn.2021.02.009_bib33","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3174\/ajnr.A5596","article-title":"Transforaminal lumbar puncture: an alternative technique in patients with challenging access","volume":"39","author":"Nascene","year":"2018","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.ejpn.2021.02.009_bib34","doi-asserted-by":"crossref","DOI":"10.1177\/1756286419887616","article-title":"Intrathecal nusinersen administration in adult spinal muscular atrophy patients with complex spinal anatomy","volume":"13","author":"Cordts","year":"2020","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.ejpn.2021.02.009_bib35","doi-asserted-by":"crossref","DOI":"10.1111\/ene.14245","article-title":"Computed-tomography-guided transforaminal intrathecal nusinersen injection in adults with spinal muscular atrophy type 2 and severe spinal deformity. Feasibility, safety and radiation exposure considerations","author":"Spiliopoulos","year":"2020","journal-title":"Eur. J. Neurol."},{"issue":"3","key":"10.1016\/j.ejpn.2021.02.009_bib36","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s00247-017-4031-6","article-title":"Transforaminal intrathecal delivery of nusinersen using cone-beam computed tomography for children with spinal muscular atrophy and extensive surgical instrumentation: early results of technical success and safety","volume":"48","author":"Weaver","year":"2018","journal-title":"Pediatr. Radiol."},{"issue":"12","key":"10.1016\/j.ejpn.2021.02.009_bib37","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1007\/s00247-018-4206-9","article-title":"A\u00a0comprehensive institutional overview of intrathecal nusinersen injections for spinal muscular atrophy","volume":"48","author":"Mousa","year":"2018","journal-title":"Pediatr. Radiol."},{"issue":"2","key":"10.1016\/j.ejpn.2021.02.009_bib38","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s10072-018-3622-9","article-title":"Intrathecal nusinersen treatment for SMA in a dedicated neuromuscular clinic: an example of multidisciplinary and integrated care","volume":"40","author":"Sansone","year":"2019","journal-title":"Neurol. Sci."},{"issue":"5","key":"10.1016\/j.ejpn.2021.02.009_bib39","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1212\/CPJ.0000000000000718","article-title":"A\u00a0multidisciplinary approach to dosing nusinersen for spinal muscular atrophy","volume":"9","author":"Zingariello","year":"2019","journal-title":"Neurol Clin Pract"},{"issue":"5","key":"10.1016\/j.ejpn.2021.02.009_bib40","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00234-019-02189-x","article-title":"Radiation exposure of image-guided intrathecal administration of nusinersen to adult patients with spinal muscular atrophy","volume":"61","author":"Oldenburg","year":"2019","journal-title":"Neuroradiology"},{"issue":"914","key":"10.1016\/j.ejpn.2021.02.009_bib41","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1259\/bjr\/88081058","article-title":"Radiation protection in humans: extending the concept of as low as reasonably achievable (ALARA) from dose to biological damage","volume":"77","author":"Prasad","year":"2004","journal-title":"Br. J. Radiol."},{"issue":"1","key":"10.1016\/j.ejpn.2021.02.009_bib42","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1038\/s41598-020-60240-x","article-title":"Radiation dose reduction for CT-guided intrathecal nusinersen administration in adult patients with spinal muscular atrophy","volume":"10","author":"Cordts","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpn.2021.02.009_bib43","series-title":"Radiation Risks from Medical X-Ray Examinations as a Function of the Age and Sex of the Patient","author":"Wall","year":"2011"},{"issue":"948","key":"10.1016\/j.ejpn.2021.02.009_bib44","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1259\/bjr\/93277434","article-title":"National survey of doses from CT in the UK: 2003","volume":"79","author":"Shrimpton","year":"2006","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.ejpn.2021.02.009_bib45","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.3389\/fneur.2019.01166","article-title":"Clinical implication of dosimetry of computed tomography- and fluoroscopy-guided intrathecal therapy with nusinersen in adult patients with spinal muscular atrophy","volume":"10","author":"Kizina","year":"2019","journal-title":"Front. Neurol."}],"updated-by":[{"DOI":"10.1016\/j.ejpn.2021.04.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000}}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379821000507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379821000507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T10:12:57Z","timestamp":1617099177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379821000507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":45,"alternative-id":["S1090379821000507"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2021.02.009","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ejpn.2021.04.001","asserted-by":"object"}]},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pediatric SMA patients with complex spinal anatomy: Implementation and evaluation of a decision-tree algorithm for administration of nusinersen","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2021.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}